# The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-renal-hemodynamic-effects-of-the-sglt2-inhibitor-dapagliflozin-are-caused-by/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Erik J.M. van Bommel,Marcel H.A. Muskiet,Michaël J.B. van Baar,Lennart Tonneijck,Mark M. Smits,Anna L. Emanuel,Andrea Božović,A.H. Jan Danser,Frank Geurts,Ewout J. Hoorn,Daan J. Touw,Emil List Larsen,Henrik E. Poulsen,Mark H.H. Kramer,Max Nieuwdorp,Jaap A. Joles,Daniël H. van Raalte |
| Citations | 350 |
| DOI | 10.1016/j.kint.2019.09.013 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://pure.amsterdamumc.nl/en/publications/6409c50f-715d-4a24-a4ce-7d878b6f9053 |
| OpenAlex ID | https://openalex.org/W2980268988 |
| PMID | 31791665 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Max Nieuwdorp](https://scholariq.org/researchers/max-nieuwdorp/)
- [Daniël H. van Raalte](https://scholariq.org/researchers/daniel-h-van-raalte/)

## Paper journal

- [Kidney International](https://scholariq.org/journals/kidney-international/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.